ATLANTA--(BUSINESS WIRE)--Shionogi Pharma, Inc. today reminds healthcare providers that its Nitrolingual® Pumpspray (nitroglycerin lingual spray), approved by the U.S. Food and Drug Administration (FDA) in 2002, is a viable alternative to nitroglycerin tablets and can be considered by healthcare professionals looking for treatment options for the many patients currently in need.
